SUMMARY
-ATPase, SPCA2, is upregulated in breast cancer-derived cells and human breast tumors, and suppression of SPCA2 attenuates basal Ca 2+ levels and tumorigenicity. Contrary to its conventional role in Golgi Ca 2+ sequestration, expression of SPCA2 increased Ca 2+ influx by a mechanism dependent on the store-operated Ca 2+ channel Orai1. Unexpectedly, SPCA2-Orai1 signaling was independent of ER Ca 2+ stores or STIM1 and STIM2 sensors and uncoupled from Ca 2+ -ATPase activity of SPCA2. Binding of the SPCA2 amino terminus to Orai1 enabled access of its carboxyl terminus to Orai1 and activation of Ca 2+ influx. Our findings reveal a signaling pathway in which the Orai1-SPCA2 complex elicits constitutive store-independent Ca 2+ signaling that promotes tumorigenesis.
INTRODUCTION

Basal Ca
2+ concentrations are tightly controlled within a narrow submicromolar range by an array of Ca 2+ channels and pumps that are susceptible to dysregulation in cancer. Transient changes in cytosolic Ca 2+ induce downstream signaling events, which regulate a wide range of cellular functions (Berridge et al., 2003; Clapham, 2007; Roderick and Cook, 2008) . Ca 2+ signaling is required for every stage of the eukaryotic cell cycle, including activation and expression of transcriptional factors and cyclindependent kinases that are necessary for cell-cycle progression (Hogan et al., 2003; Roderick and Cook, 2008) , as well as centrosome duplication and separation (Fukasawa, 2007; Matsumoto and Maller, 2002) . Crosstalk with other signaling mechanisms, such as the Ras pathway, regulates cell-cycle transition and cell proliferation (Cook and Lockyer, 2006; Cullen and Lockyer, 2002) . Dynamic regulation of Ca 2+ signaling is achieved by cooperation of various cellular components including receptors, channels, transporters, buffering proteins, and downstream effectors (Berridge et al., 2003) . Thus, inappropriate activation of Ca 2+ influx channels or downregulation of Ca 2+ efflux and sequestration mechanisms could increase basal Ca 2+ to augment Ca 2+ signaling and tumor cell proliferation. Alternatively, changes that deplete the endoplasmic reticulum (ER) Ca 2+ store can confer cellular resistance to apoptosis (Monteith et al., 2007) . In most nonexcitable cells, depletion of ER stores elicits sustained Ca 2+ influx by store-operated Ca 2+ (SOC) entry, defining the major Ca 2+ influx pathway. Upon the stimulation of cellsurface receptors, depletion of ER Ca 2+ results in release of Ca 2+ from lumenal EF hand domains of ER-localized STIM proteins, triggering their translocation to ER-plasma membrane junctions where they bind and activate Orai1, the pore subunit of the Ca 2+ release-activated Ca 2+ (CRAC) channel, and resulting in refilling of ER stores (Cahalan et al., 2007; Gwack et al., 2007; Lewis, 2007; Vig and Kinet, 2007) . influx is essential for maintaining ER Ca 2+ content at a precise level and functions in various physiological processes such as gene transcription, cell-cycle progression, and apoptosis (Parekh and Putney, 2005) . Dysfunction of store-operated Ca 2+ signaling mediated by STIM and Orai1 leads to inhibition of physiological and pathophysiological activities including breast tumor cell migration and tumor metastasis (Yang et al., 2009) , vascular smooth muscle cell proliferation and migration (Potier et al., 2009) , and T cell activation and tolerance (Oh-Hora et al., 2008) .
The Secretory Pathway Ca 2+ -ATPases (SPCA) are ATP-powered pumps that deliver Ca 2+ and Mn 2+ ions into the Golgi lumen for protein sorting, processing, and glycosylation (Durr et al., 1998) . In higher vertebrates, including human, this essential function is carried out by the ubiquitously expressed SPCA1 isoform, with orthologs in lower eukaryotes including yeast, nematode, and fruit fly (Missiaen et al., 2007) . A closely related second isoform, SPCA2, shares similar transport characteristics and appears at first glance to have a redundant role, given its absence in lower eukaryotes (Vanoevelen et al., 2005; Xiang et al., 2005) . The limited tissue distribution of SPCA2 includes mammary epithelium, where it is sharply upregulated during lactation. Whereas SPCA1 showed a modest 2-fold induction upon lactation, SPCA2 increased by 35-fold and was localized to the lumenal secretory cells of the mammary gland (Faddy et al., 2008) .
We hypothesized that transformation of mammary epithelial cells to a cancerous phenotype would be accompanied by dysregulation of Ca 2+ transporters and their downstream signaling pathways, augmenting proliferation and tumor formation. Furthermore, localized, inappropriate secretion of Ca 2+ in the absence of calcium buffers could result in microcalcifications that appear as radiographic ''signatures'' on mammograms used in diagnosis of breast cancer (Morgan et al., 2005) . Although microcalcifications have been extensively used to characterize abnormalities in the breast tissue, a mechanistic understanding of the source of calcium and the specific pathways that lead to their deposition has remained elusive.
In this study, we show that SPCA2 elicits constitutive Ca signaling, mediated by Orai1, which correlates with oncogenic activities of mammary tumor cells. Unexpectedly, SPCA2-induced Ca 2+ signaling was independent of its Ca 2+ pump activity, and not regulated by store depletion or STIM proteins. SPCA2 interacted with Orai1 by its N terminus and activated Ca 2+ influx by the C terminus. These findings reveal a Ca 2+ signaling mechanism in which Orai1 mediates store-independent Ca 2+ influx, and dysregulation of SPCA2 constitutively activates this pathway leading to oncogenic activity of tumor cells.
RESULTS
Upregulation of SPCA2 Induces Oncogenic Signaling in Mammary Tumor Cells
We used quantitative RT-PCR to investigate the expression of SPCA isoforms in a range of breast cancer-derived and nonmalignant mammary epithelial cells. In contrast to comparable mRNA levels of SPCA1, SPCA2 was highly upregulated in lumenal-like breast cancer-derived cell lines ( Figure 1A ). Examination of mRNA levels in breast tissue from a small pool of breast cancer patients confirmed this upregulation ( Figure 1B ) and prompted us to mine data from microarray profiles of 295 primary human breast tumors: highest levels of SPCA2 were found in ERBB2 + tumors, among five transcriptional subtypes ( Figure S1 available online). Consistent with mRNA levels, protein expression of SPCA2 was higher in MCF-7 cells, a human breast adenocarcinoma cell line, relative to MCF-10A, a nonmalignant human mammary epithelial cell line; in contrast, there was no increase in SPCA1 expression in MCF-7 ( Figure 1C ). We used lentiviral delivery of shRNA constructs to knock down expression of endogenous SPCA proteins in MCF-7 cells ( Figure 1D ). Proliferation was inhibited in SPCA2 KD cells, with growth rates slower than mock-transduced cells, and similar to cells growing in low extracellular Ca 2+ (0.1 mM). In contrast, SPCA1 KD did not cause this growth phenotype ( Figure 1E ). The RAS-RAF-MEK-ERK1/2 pathway is known to play an essential role in cell proliferation and survival. Phosphorylation of ERK1/2 drives activation of transcriptional factors and expression of downstream proteins such as cyclin D1, which is essential for completion of the G1/S transition (Coleman et al., 2004; Roderick and Cook, 2008) . Levels of phospho-ERK and cyclin D1 reduced dramatically in SPCA2
KD cells, as well as in cells incubated in low extracellular Ca 2+ , relative to control cells ( Figure 1F ).
We examined the effects of depleting endogenous SPCA2 on the transformed phenotype of MCF-7 cells by monitoring growth of cells in soft agar. Fewer and smaller colonies were observed in soft agar seeded with SPCA2
KD cells compared to control cells, and normalized results showed a clear reduction of growth in SPCA2
KD cells ( Figure 1G ). Conversely, overexpression of SPCA2 in nontumorigenic MCF-10A cells conferred the ability to form colonies in soft agar ( Figure 1H ) and increased proliferation rate ( Figure 1I ). We also monitored tumor generation in nude mice injected subcutaneously in the flank with control or SPCA2 KD MCF-7 cells. We show that SPCA2 KD conferred only sporadic and delayed tumor formation relative to control ( Figure 1J ).
To determine whether oncogenic activity of endogenous SPCA2 was mediated by Ca 2+ signaling, we measured basal (Clementi and Meldolesi, 1996) , and 2-APB (Parekh and Putney, 2005) at the reported concentrations, and in low extracellular Ca
2+
, indicating Ca 2+ entry through plasma membrane Ca 2+ channels. Inhibition of the Ca 2+ -activated Ser/Thr phosphatase calcineurin by FK506 also prevented nuclear relocalization of NFAT-GFP in SPCA2-transfected cells (Figures 2A and 2B ). Accordingly, NFAT was predominantly dephosphorylated in TG-treated-or SPCA2-expressing cells but remained phosphorylated in cells transfected with SPCA1 or empty vector and in FK506-treated cells ( Figure 2C ). These findings were unexpected, given the known function of SPCA2 in pumping Ca 2+ away from the cytoplasm into Golgi/vesicular stores. To determine whether constitutive Ca 2+ signaling elicited by SPCA2 was dependent on its Ca 2+ pumping ability, we generated two variants: mutant D379N lacks the conserved and essential aspartate that is transiently phosphorylated by ATP in the catalytic cycle, and mutant D772A disrupts -binding site ( Figure 2D ) (Wei et al., 2000) . Both mutants failed to rescue growth of a yeast strain lacking endogenous Ca 2+ pumps in BAPTA-supplemented medium, consistent with loss of Ca 2+ -ATPase activity ( Figure 2E ), but retained ability to elicit constitutive NFAT translocation in HEK293 cells ( Figure 2F ). Also, mutant D379N induced growth of MCF-10A in soft agar similar to wild-type (WT) SPCA2 ( Figure S2B ). Furthermore, introduction of SPCA2, either WT or D379N mutant, resulted in elevated basal cytoplasmic Ca 2+ levels in HEK293 cells, relative to cells transfected with empty vector or SPCA1 ( Figure 2G ). This was reminiscent of the effect of upregulation of endogenous SPCA2 on basal Ca 2+ levels in MCF-7 cells ( Figure 1K ). We conclude that SPCA2, but not SPCA1, induces constitutive Ca 2+ influx and signaling by a mechanism that is independent of its known function as a Ca 2+ -ATPase.
SPCA2-Mediated Ca 2+ Signaling Is Store Independent
To investigate the possibility that SPCA2 could elicit ER Ca 2+ store depletion leading to constitutive store-operated Ca 2+ entry (SOCE), we examined the status of the ER Ca 2+ store. YFP-STIM1, the ER-localized Ca 2+ sensor protein, was present in a reticular, ER-like pattern in resting cells and redistributed to punctae after store depletion with thapsigargin (Liou et al., 2005) , as expected ( Figure 3A ). Transient transfection with SPCA2 did not elicit puncta formation of YFP-STIM1, suggesting that the ER store was not Ca 2+ depleted ( Figure 3A ). Next, we directly measured the ER Ca 2+ content by ionomycin treatment to completely release Ca 2+ from intracellular stores. In Ca 2+ -free medium, peak levels of Ca 2+ released by ionomycin were identical in cells transfected with SPCA2 or empty vector (Figure 3B and Figures S3A and S3B) . In a different, independent approach, we used a thapsigargin-insensitive, ER-localized Ca 2+ -ATPase to ensure that intracellular ER stores were replete with Ca
2+
. N-terminal GFP-tagged SPCA1 partially mislocalized to the ER ( Figure S3C ) where it is functional in filling the stores and preventing nuclear translocation of NFAT-mCherry after thapsigargin treatment ( Figure S3D and Figures 3C and 3D ). Despite coexpression with ER-localized GFP-SPCA1, SPCA2 was capable of eliciting nuclear translocation of NFAT-mCherry ( Figures 3C and 3D ). HA-tagged SPCA1 localizes to the Golgi ( Figure S3C ) and does not interfere with thapsigargin-induced SOCE, nor with SPCA2-induced nuclear translocation of NFAT-mCherry ( Figure 3D ), indicating that Ca 2+ signaling by SPCA2 is also independent of Golgi stores. It was previously reported that knockdown of STIM1 or expression of the dominant-negative mutant D76A DERM blocked SOC signaling (Huang et al., 2006; Roos et al., 2005) , as seen by the failure of TG to elicit nuclear translocation of NFAT ( Figure 3E and Figures  S3E and S3F) . Also, knockdown of STIM2, the feedback regulator of cytosolic and ER Ca 2+ levels, was shown to lower basal Ca 2+ concentration (Brandman et al., 2007) (Figures S3E and S3G) . However, despite expression of dominant-negative D76A DERM or knockdown of STIM1 and STIM2 expression, either singly or in combination, SPCA2 retained the ability to increase basal Ca 2+ concentration and cause NFAT-GFP translocation to the nucleus, evidently by a STIM-independent Ca 2+ signaling mechanism ( Figure 3E and Figures S3F and S3G uptake ( Figures S4A and S4B ). Initial rates of uptake, monitored within the first 60 s, were significantly increased by expression of SPCA2 ( Figure 3F and Figures S4D-S4I influx was independent of ER stores, we observed coimmunoprecipitation of the endogenous store-operated channel Orai1 and native SPCA2 in MCF-7 cells ( Figure 4C ). We verified and extended these findings using epitope-tagged proteins expressed in HEK293 cells: we could document robust coimmunoprecipitation of Orai1-Myc and HA-SPCA2 ( Figure 4D ). Consistent with the specificity of the Orai1-SPCA2 interaction, HA-SPCA1 did not coimmunoprecipitate with Orai1 ( Figure 4D ). Similar to endogenous protein, up to 10% of HA-SPCA2 could be labeled by cell-surface biotinylation, including both WT and the pump-inactive D379N mutant; in contrast, SPCA1 was barely detectable ( Figure 4E ). Surface residence of SPCA2 correlated with total expression levels, and with elevation of basal Ca 2+ ( Figure S5A ). We also used cell-surface biotinylation to confirm that a portion of SPCA2-complexed Orai1 was found at the plasma membrane ( Figures S5B and S5C ). Although SPCA2 preferentially interacted with lower molecular weight bands of posttranslationally modified Orai1 as has been reported for STIM1 (Park et al., 2009; Vig et al., 2006) , we confirmed that all forms of Orai1 reached the plasma membrane where they could be biotinylated ( Figure 4B ). Epitope-tagged SPCA2 and Orai1 also partially colocalized by confocal immunofluorescence (F) Initial rates of Ca 2+ influx in HEK293 cells with or without SPCA2 expression, calculated from the experiments shown in Figure S4 , with 0.5 mM, 1.0 mM, or 2.0 mM extracellular Ca 2+ . Vector: n = 30 (0.5 mM), 25 (1.0 mM), 28 (2.0 mM); SPCA2: n = 28 (0.5 mM), 23 (1.0 mM), 25 (2.0 mM).
Representative Ca 2+ traces (G) and average intracellular Ca 2+ concentration representing store-independent Ca 2+ influx (H) and internal Ca 2+ store content (I) in microscopy ( Figure S5D ). Unlike STIM (Yeromin et al., 2006) , interaction between SPCA2 and Orai1 was not affected by store depletion with thapsigargin, consistent with a store-independent regulation of Orai1 function ( Figure S5E ). Supporting this possibility, neither WT STIM1 nor the constitutively active STIM1 mutant (D76A) (Huang et al., 2006; Liou et al., 2005) was in the same protein complex as SPCA2 ( Figure S5F ). These findings point to Orai1 as a likely candidate for mediating SPCA2-regulated, store-independent Ca 2+ influx in breast cancer cells.
To evaluate this possibility, we suppressed the expression of endogenous Orai1 in MCF-7 cells: Orai1 KD lowered basal Ca 2+ to levels comparable to those seen upon depleting endogenous SPCA2 ( Figure 4F ). In addition, Orai1 KD in MCF-7 cells suppressed cell proliferation ( Figure 4G ) and inhibited the RAS pathway, as did SPCA2 KD ( Figure 4H and Figure S5G ). Furthermore, Orai1 KD suppressed colony formation in soft agar, to a similar extent as SPCA2 KD ( Figure 4I ), and tumor generation in nude mice ( Figure 4J ). Simultaneous knockdown of both Orai1 and SPCA2 did not confer additive phenotypes ( Figures  S5H, S5J , and S5K). In MCF-10A cells overexpressing SPCA2, cell transformation and elevation of basal Ca 2+ level were reversed by knockdown of Orai1, consistent with a role for Orai1 downstream of SPCA2 ( Figures 4K-4L and Figure S5L ). As expected for a store-independent mechanism of Orai1 activation, depletion of STIM1 ( Figures S5M-S5O ) or STIM2 ( Figures  S5I-S5K) , the upstream activators of Orai1 in SOCE signaling, did not confer comparable phenotypes in MCF-7 cells. Taken together, our data point to promotion of tumorigenic pathways by SPCA2 in breast cancer cells, mediated by interaction with Orai1.
Amino Terminus of SPCA2 Interacts with Orai1
To dissect the molecular determinants of the SPCA2-Orai1 interaction, we evaluated the efficiency of coimmunoprecipitation between a series of SPCA chimeric proteins and Orai1. In each case, the ability of a chimeric protein to coimmunoprecipitate with Orai1 correlated with ability to elicit NFAT translocation, suggesting that physical interaction between the two proteins was required for Ca 2+ signaling. Chimeras containing the SPCA2 N terminus showed stronger binding with Orai1 and more effective NFAT translocation ( Figures 5A-5C ). Next, we examined physical interaction between Orai1 and major intracellular soluble domains of SPCA2, including N and C termini and the large intracellular loop, which contains the iconic aspartate of P-type ATPases (D379). Of these, only the N terminus was able to pull down Orai1 ( Figure 5D ). To further map regions within the SPCA2 N terminus responsible for binding to Orai1, we performed GST pull downs between Orai1 and a series of SPCA1 and SPCA2 fragments. The SPCA1 N terminus did not bind to Orai1, consistent with an absence of functional interaction between SPCA1 and Orai1 ( Figure 5E ). A region of 40 amino acids within the N terminus of SPCA2 was able to effectively interact with Orai1 ( Figure 5E ; construct . Surprisingly, this region was highly conserved between the two isoforms, with 50% amino acid identity ( Figure S6A ). We therefore conducted mutational replacement of amino acids in the SPCA2 N terminus with the equivalent residues in SPCA1 and identified four amino acids that together were critical for interaction between the SPCA2 N terminus and Orai1 ( Figure 5F ). Three-dimensional structure of the SPCA2 N terminus, predicted by I-TASSER server (Wu et al., 2007) , suggested that Val71, Thr75, and Ser78 were spatially clustered, whereas Val95 was on the remote side ( Figure 5G, Figures S6B and S6C , and Table S1 ).
Finally, we evaluated the effect of Orai1 expression on the intracellular localization of N-terminal fragments of SPCA1 and SPCA2 in HEK293 cells. When expressed alone, both fragments were localized intracellularly, with the SPCA1 N-terminal fragment diffusely distributed in the cytosol, and the SPCA2 N terminus concentrated in the perinuclear region. Although the coexpression of Orai1 did not change localization of the SPCA1 N terminus, there was a redistribution of the SPCA2 N terminus to the cell surface, providing additional evidence that the N-terminal domain of SPCA2, but not SPCA1, interacts physically with Orai1 ( Figure 5H ).
Cooperation of SPCA2 N and C Termini in Ca 2+ Signaling
We further investigated the molecular mechanism of SPCA2-activated Ca 2+ signaling. We noticed that the isolated N terminus of SPCA2 did not elicit NFAT translocation despite being able to interact directly with Orai1, while the C terminus was sufficient to induce NFAT translocation when it was linked to two or more transmembrane domains and targeted to the membrane ( Figure 6A and Figures S7A and S7B) . Surprisingly, a similar membrane-anchored construct containing the SPCA1 C terminus was also able to activate constitutive Ca 2+ signaling even though full-length SPCA1 could not ( Figure 6A ). In addition, both SPCA1 and SPCA2 membrane-anchored C-terminal domains physically interacted with Orai1 ( Figure S7C ). We hypothesized that access of the SPCA C terminus to Orai1 was blocked in the full-length proteins, and binding of the SPCA2 N terminus to Orai1 led to exposure of the C terminus and activation of downstream Ca 2+ signaling. Analysis of deletion and point mutants of the SPCA2 C terminus identified essential functional residues including several positive charges (lysines and arginines) and a putative PDZ binding domain (Figure 6A and Figure S7D ), conserved between human, rat, and mouse SPCA proteins ( Figure S7E ). We then measured intracellular Ca 2+ concentrations upon expression of SPCA2 C-terminal constructs in HEK293 cells. Basal Ca 2+ level was elevated dramatically by expression of the SPCA2 C terminus but remained the same as GST control when lysines (arginines) were mutated or the putative PDZ domain was deleted ( Figure 6B ). The N-terminal domain of SPCA2, but not SPCA1, had a dominant-negative effect, dramatically inhibiting NFAT translocation induced by full-length SPCA2 or the C terminus ( Figure 6C ), whereas SOCE was not blocked by the SPCA2 N terminus or full-length with the C terminus deleted (SPCA2 D924-946) ( Figure S7F ). Importantly, expression of the membrane-anchored SPCA2 C terminus in MCF-10A cells was able to induce cell transformation, consistent with the fact that it was identified to be the functional domain of SPCA2 and elicited constitutive Ca 2+ signaling ( Figure 6D ). STIM1 CRAC activation domain (Park et al., 2009 ) showed a similar effect, supporting the role of Ca 2+ signaling in cell transformation ( Figures S7G   and S7H ).
Cell 143, 84-98, October 1, 2010 ª2010 Elsevier Inc. 91 We next expressed GST fusions of various Orai1 domains including N and C termini, extra-and intracellular loops together with full-length SPCA2 or the N-terminal fragment of SPCA2. Both N and C termini, but not the loops of Orai1, were able to pull down both full-length and N terminus of SPCA2, revealing that SPCA2 and Orai1 interacted within the cytoplasm (Figures 6E and 6F) . We then mapped subregions of Orai1 N and C termini to further explore SPCA2 interaction domains ( Figure 6G ). GST pull-down experiments identified a fragment (aa 48-91) of the Orai1 N terminus that bound SPCA2 with a higher affinity than the full-length N terminus. Mutation L273S, previously shown to disrupt the coiled-coil domain of the C terminus of Orai1 (Muik et al., 2008) , severely reduced the interaction with SPCA2 ( Figure 6G ). Taken together, we propose a model for SPCA2 interaction with Orai1 and activation of Ca 2+ signaling. We suggest that the N terminus of SPCA2 binds Orai1, resulting in a conformational change and exposure of the C terminus, which can interact with Orai1 either directly or together with other proteins to activate Ca 2+ influx ( Figure S7I ).
DISCUSSION
Role of SPCA2 and Orai1 in Breast Tumorigenicity
Our findings reveal a mechanism for activation of the so-called SOCE channel Orai1 that is independent of ER and Golgi Ca 2+ stores and sensors. This store-independent mode of endogenous Orai1 activation in breast cancer-derived MCF-7 cells underlies constitutive Ca 2+ signaling, proliferation, and anchorage-independent growth and implicates a hitherto unrecognized role for Orai1 in breast tumorigenicity. We also identified a role for SPCA2 in tumorigenicity and revealed a functional link to RAS signaling. The RAS-ERK pathway regulates cell-cycle progression and cell proliferation, and it is well known that hyperactivation of the RAS gene family correlates with various human cancers (Bos, 1989) . GTP-exchange factors (GEFs) and GTPase-activating proteins (GAPs) control activity of RAS by regulating the balance of GTP binding and hydrolysis (Donovan et al., 2002; Downward, 1996 oscillation (Cook and Lockyer, 2006) . By monitoring activation of ERK and expression of the downstream protein cyclin D1, we revealed a correlation between SPCA2 and Orai1-mediated increase of basal Ca 2+ levels and constitutive activation of RAS signaling in MCF-7 cells, placing the SPCA2-Orai1 pathway in the RAS signaling network.
Mechanism of Orai1-Mediated Ca 2+ Signaling Induced by SPCA2 It has been reported that STIM1 and Orai1 mediate CRAC currents in endothelial cells, and knockdown of either elicits cell-cycle arrest (Abdullaev et al., 2008) . Another recent study implicated a store-dependent role for Orai1 in cell migration of the metastatic breast cancer line MDA-MB-231, based on a requirement for STIM1 (Yang et al., 2009) . We note that SPCA2 expression is very low in MDA-MB-231 (data not shown), consistent with a Ca 2+ signaling mechanism distinct from the store-independent pathway reported here. Although the importance of SOC signaling is well established, the store independent Ca 2+ signaling described in our study suggests that multiple mechanisms may invoke Orai1 activation. Interaction between SPCA2 and Orai1 was not affected by ER store depletion and activation of SOC signaling, and SOCE was not inhibited by expression of SPCA2, supporting that SPCA-induced signaling may function independently of the SOC pathway and different pools or fine subdomains of Orai1 are involved in the two pathways. ER-localized Ca 2+ sensor STIM proteins, which regulate SOCE, did not physically interact with SPCA2 or participate in regulation of the SPCA2-Orai1 signaling pathway. In addition, internal Ca 2+ store content was not depleted by suppression or overexpression of SPCA2. Thus, it remains to be determined how the store-independent, Orai1-mediated mechanism of Ca 2+ influx is regulated. One possibility is that signaling activity of SPCA2 is regulated by its trafficking between Golgi and plasma membrane. Interaction with Orai1 at the cell surface may be dependent on a specific conformation of SPCA2, which could be regulated by kinase-mediated phosphorylation, Ca 2+ binding, or changes in pH between extracellular and Golgi lumen. Removal of a potential PDZ-binding motif in the last four residues of the C-terminal tail of SPCA2 abolished Ca 2+ signaling, suggesting that interaction with scaffold proteins may be important for activation of this signaling pathway.
Based on the function of a series of chimeras and mutant proteins, we propose a model in which cooperation of N and C termini of SPCA2 is required for Orai1-mediated Ca 2+ signaling. Whereas the N terminus of SPCA2 binds strongly to Orai1, the C terminus elicits activation of Ca 2+ influx. Although the Orai1-binding domain within the SPCA2 N terminus is highly conserved with the corresponding region of SPCA1, no interaction was detected between the SPCA1 N terminus and Orai1. Replacement of four residues within the minimal Orai1-binding domain of the SPCA2 N terminus (Val71, Thr75, Ser78, and Val95) to the corresponding less hydrophobic or charged residues in SPCA1 abolished the interaction with Orai1. Interestingly, C-terminal constructs of both SPCA isoforms, anchored to the membrane by a minimum of two transmembrane helices, were able to elicit Ca 2+ influx and signaling.
Consistent with this, critical amino acids within the C terminus were conserved in both isoforms from rat, mouse, and human.
Therefore, we propose a mechanism in which accessibility of SPCA C termini is blocked in the full-length protein and binding of the N terminus to Orai1 is required for functional availability of the C terminus. Consistent with this hypothesis, we find that expression of the soluble N-terminal domain from SPCA2, but not SPCA1, has a dominant-negative effect in blocking activation of Ca 2+ signaling. Long-range conformational interactions between the N terminus and other cytosolic domains have been noted in SPCA and other P-type pumps, as well as changes in accessibility of the C-terminal tail (Huster and Lutsenko, 2003; Lecchi et al., 2005; Wei et al., 1999) . Recently, Garside et al. (2010) identified an alternative transcript of SPCA2, encoding an 20 kDa membrane-anchored C-terminal fragment, in tissues including brain, testes, salivary glands, and pancreas. Expression of this transcript was under the control of MIST1, a basic helix-loop-helix transcription factor, and appeared to be independent of the full-length transcript. This suggests the intriguing possibility that a C-terminal fragment of SPCA2 may elicit Ca 2+ signaling independent of the full-length transporter.
Physiological and Pathophysiological Perspectives of SPCA2-Induced Ca 2+ Signaling The conventional role of ATP-powered Ca 2+ pumps is to scavenge and extrude cytoplasmic Ca 2+ in order to terminate a signal, and as a prerequisite for additional signaling events. Unexpectedly, high levels of expression of the Ca 2+ efflux pump SPCA2
increased rather than lowered basal cytoplasmic Ca 2+ levels, and conversely, attenuation of SPCA2 expression was accompanied by a decrease in basal Ca 2+ . We speculate that this unconventional mechanism may be physiologically important in eliciting high rates of transcellular Ca 2+ flux during lactation (Lee et al., 2006) and in other Ca 2+ -secreting tissues, including salivary glands and intestinal epithelia, where SPCA2 is expressed at high levels. Total calcium concentration in milk can reach up to 100 mM, five to six orders of magnitude greater than typical cytoplasmic concentrations (0.1 mM). Thus, there must be energy-dependent transport processes for effective transcellular movement of Ca 2+ from blood into milk. In mammary gland, a 30-fold transcriptional increase in the plasma membrane Ca 2+ pump isoform, PMCA2, is accompanied by apical efflux of Ca 2+ into milk (Reinhardt et al., 2004) . Compared to modest changes in SPCA1 levels, SPCA2 was found to be upregulated during pregnancy (8-fold) and dramatically upon lactation (35-fold on day 1). Furthermore, SPCA2 expression was restricted to the lumenal cells of lactating glands (Faddy et al., 2008 (Mamillapalli et al., 2008) . Thus, the upregulation of SPCA2 in the altered signaling environment of tumor cells may result in constitutive Ca 2+ signaling and cell growth. Inappropriate secretion of Ca 2+ from these cells, in the absence of calcium buffers, could lead to microcalcifications that are diagnostic of breast cancer. Finally, the separation of signaling function from transport activity in SPCA2, evidenced by our findings, is highly unusual in pumps. An extreme case is SUR1, an ABC transporter that lacks known transport activity but is essential for conferring ATP sensitivity to K ATP channels in insulin-secreting pancreatic b cells (Aittoniemi et al., 2009 ). In summary, we identified a store-independent SPCA2-Orai1 signaling pathway. Upregulation of SPCA2 led to constitutively active Ca 2+ signaling and correlated with oncogenic activity in breast cancer. Both SPCA2 and Orai1 emerge as druggable targets of therapeutic potential in the treatment of some breast cancer subtypes.
EXPERIMENTAL PROCEDURES
Materials and additional experimental procedures are described in the Supplemental Information. (Chang et al., 2005) . One probe on the array (annotated as KIAA0703) corresponded to SPCA2. Tumors were grouped by transcriptional subtype and analyzed for SPCA2 expression. Statistical significance between groups was assessed by comparing medians using the KruskallWallis test followed by Dunn's Multiple Comparison Test (Prism version 5, Graphpad Inc.).
SPCA2 Analysis in Human Breast Tumors
NFAT Translocation Assay
Monitoring of nuclear translocation of NFAT was performed 24 hr post-transfection in HEK293 cells. Fresh medium was added 2 hr before the start of the experiment. Localization of NFAT-GFP and NFAT-mCherry in cells was examined by fluorescent microscopy. 100-300 cells were manually counted on each coverslip, 3 wells for each condition, and the fraction of cells with nuclear NFAT was calculated. Where indicated, 2 mM thapsigargin was added for 30 min, 10 mM miconazole was used for 1 hr, and 50 mM 2-APB was used for 1 hr.
Calcium Imaging and Mn 2+ Quench
Cells were loaded with Fura-2 AM at 1 mg/ml in calcium recording buffer (126 mM NaCl, 2 mM MgCl 2 , 4.5 mM KCl, 10 mM Glucose, 20 mM HEPES pH 7. Construction, Production, and Infection of Lentiviruses and Retroviruses Replication-incompetent lentivirus was used to package shRNA for knockdown in MCF-7 cells and HEK293 cells. Cells were incubated with viruses for 48 hr and selected with puromycin (2-4 mg/ml). Retroviral gene transfer and expression system (Clontech, Mountain View, CA, USA) was used for stable expression of SPCA2 in MCF-10 cells. SPCA2 gene was cloned into pLXRN vector to package retroviruses. Viruses were collected 48 hr after transfection and added to MCF-10A cells. Cells were treated with G418 (400 mg/ml) after 48 hr infection and selected cells were used to assay proliferation and colony formation in soft agar.
Cell Proliferation Assay
Proliferation was monitored using a Celltiter 96 Aqueous One Solution cell proliferation assay kit (Promega, Madison, WI, USA) according to manufacturer's instructions. Briefly, 0.5-1 3 10 4 cells were plated into a 96-well plate.
After every 24 hr, 20 ml of Celltiter 96 Aqueous One Solution reagent was added to each well and incubated for 2 hr at 37 C, 5% CO 2 . The absorbance at 490 nM was recorded using a 96-well plate reader.
Colony Formation in Soft Agar
Colony formation in soft agar assay was performed using a CytoSelect 96-well cell transformation assay kit (Cell Biolabs, San Diego, CA, USA). In a 96-well plate, 0.5-1 3 10 4 cells were resuspended in DMEM containing 0.4% agar and 10% FBS and layered onto a base agar consisting of DMEM with 0.6% agar and 10% FBS. Following solidification, growth medium was added on to the cell agar layer. One to two weeks later, colonies were imaged under the microscope, the agar layer was solubilized, and cells were lysed and quantified with CyQuant GR dye. The plate was read in a FLUOstar Optima plate reader (BMG Labtechnologies) using a 485/520 nm filter set.
Tumor Formation in Nude Mice
Female 4-to 6-week-old athymic nude mice (NCI) were received by the animal facility personnel and acclimated at the facility for 2 weeks. Estrogen pellets (SE-121, 0.72 mg/pellet, 60 days release) were obtained from Innovative Research of America. For each animal, a pellet was implanted into the back of the neck through a 1 cm cut and the wound was closed by a wound clip. After 3 days of implantation, the animals were ready to be injected with cells. MCF-7 cells transduced with control or SPCA2 shRNA or Orai1 shRNA were trypsinized and diluted to 1.5-3 3 10 7 cells per ml in PBS. 3 3 10 6 cells per animal were injected subcutaneously into the flank of each of 6-10 mice. The incidence of tumor formation was recorded in each animal once per week, starting 14-18 days after injection. Animal care was in accordance with institutional guidelines. One animal with subsequent tumor necrosis was euthanized, others were sacrificed after 10 weeks of observation.
Immunofluorescence Cultured HEK293 and MCF-7 cells on coverslips were pre-extracted with PHEM buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, and 2 mM MgCl 2 , pH 6.8) containing 0.025% saponin for 2 min, then washed twice for 2 min with PHEM buffer containing 0.025% saponin and 8% sucrose. The cells were fixed with a solution of 4% PFA and 8% sucrose in PBS for 30 min at room temperature and blocked with a solution of 1% BSA and 0.025% saponin in PBS for 1 hr. Primary antibodies were diluted 1:500 in 1% BSA and incubated with the cells for 1 hr. Alexa-Fluor 488 goat anti-rabbit IgG (Invitrogen) and Alexa-Fluor 568 goat anti-mouse IgG were used at a 1:1000 dilution for 30 min. Cells were mounted onto slides using Dako Fluorescent Mounting Medium. Slides were imaged on a Zeiss LSM510-Meta confocal microscope. In Figure 4A , anti-SPCA2 was used. In Figure 5H , anti-SPCA2, anti-SPCA1, and anti-HA were used to detect SPCA2N, SPCA1N, and HA-Orai1. In Figure S3C , anti-Myc, anti-SPCA1, and anti-Golgi97 were used to detect Myc-STIM1, HA-SPCA1, and Golgi 97. In Figure S5D , anti-SPCA2 and anti-HA were used to detect Myc-SPCA2 and HA-Orai1. In Figure S7B , anti-GST and anti-HA were used to detect GST-SPCA2C and HA-Orai1.
Coimmunoprecipitation and GST Pull-Down Coimmunoprecipitation (co-IP) and GST pull-down assay in HEK293 cells were performed 24 hr after transfection. Co-IP in MCF-7 cells for endogenous proteins was performed 24-48 hr after seeding cells. Cells were lysed in lysis buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM Na 3 EDTA, 1 mM EGTA, 5 mM Na 4 P 2 O 7 , 1 mM Na 3 VO 4 , 10 mM NaF, supplemented with 1% Triton X-100 and protease inhibitor cocktail [Roche] ). 1/10 of the lysate was saved as ''input.'' For co-IP, cell lysate was incubated 1 hr with GammaBind Plus Sepharose (GE Healthcare, Waukesha, WI, USA) for preclearance and 1-4 hr with antibodies (anti-Myc or anti-SPCA2) at 4 C. GammaBind beads were added and incubated for 1 hr at 4 C. For GST pull-down assay, cell lysate was incubated 2 hr with glutathione Sepharose 4B. Beads were washed using lysis buffer supplemented with 1% Triton X-100 before SDS-PAGE and immunoblotting. 1/2 of the ''input'' and 1/2 to 1/8 of the co-IP/pull-down fraction were loaded to SDS-PAGE gels. To co-IP cell-surface Orai1 with SPCA2, cells were biotin-labeled, lysed, and immunoprecipitated using anti-SPCA2 antibody. The proteins on the GammaBind beads were eluted with lysis buffer containing 1% SDS and incubated with neutravidin resin overnight at RT. Beads were washed in the same buffer. Only the portion of Orai1 that bound to SPCA2 at the cell surface was detected using SDS-PAGE and immunoblotting. 1/2 of the ''input'' and 1/2 of the biotinylated fraction were loaded to SDS-PAGE gels.
Functional Complementation in Yeast
Yeast growth assays were performed as described before (Xiang et al., 2005) . The yeast strain K616 (pmr1Dpmc1Dcnb1D) was used as host for plasmids expressing SPCA2. Freshly grown cells were inoculated into each well of 96-well plates at 0.05 optical density (OD) 600 nm. Plates were incubated overnight at 30 C and resuspended by agitation, and OD 600 nm was measured using a FLUOstar Optima plate reader.
Three-Dimensional Structure Prediction I-TASSER method was used to predict 3D protein structure from the primary amino acid sequence of the SPCA2 N terminus. I-TASSER was ranked as the No.1 server in recent CASP7 and CASP8 experiments (Critical Assessment of Protein Structure Prediction). 
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